JP2024506435A5 - - Google Patents
Info
- Publication number
- JP2024506435A5 JP2024506435A5 JP2023525002A JP2023525002A JP2024506435A5 JP 2024506435 A5 JP2024506435 A5 JP 2024506435A5 JP 2023525002 A JP2023525002 A JP 2023525002A JP 2023525002 A JP2023525002 A JP 2023525002A JP 2024506435 A5 JP2024506435 A5 JP 2024506435A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- amino acid
- acid residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105669P | 2020-10-26 | 2020-10-26 | |
| US63/105,669 | 2020-10-26 | ||
| US202163193748P | 2021-05-27 | 2021-05-27 | |
| US63/193,748 | 2021-05-27 | ||
| PCT/US2021/047824 WO2022093373A1 (en) | 2020-10-26 | 2021-08-26 | Compounds,compositions and methods of use to treat bone fractures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506435A JP2024506435A (ja) | 2024-02-14 |
| JP2024506435A5 true JP2024506435A5 (https=) | 2024-09-03 |
Family
ID=81383093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525002A Pending JP2024506435A (ja) | 2020-10-26 | 2021-08-26 | 化合物、組成物、および骨折を処置するための使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230399374A1 (https=) |
| EP (1) | EP4232074A4 (https=) |
| JP (1) | JP2024506435A (https=) |
| AU (1) | AU2021370296A1 (https=) |
| CA (1) | CA3194776A1 (https=) |
| MX (1) | MX2023004796A (https=) |
| WO (1) | WO2022093373A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3045458A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| WO2019232283A1 (en) | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| AU2021369193A1 (en) * | 2020-10-26 | 2023-06-01 | Purdue Research Foundation | Compounds,compositions and methods of use to treat spinal fusions |
| WO2022149066A1 (en) * | 2021-01-05 | 2022-07-14 | Radius Health, Inc. | Treatment of long bone fractures with abaloparatide |
| CN117373681B (zh) * | 2023-10-30 | 2024-04-26 | 中国航天科工集团七三一医院 | 一种基于血糖调节系统作用的骨折愈合仿真方法及系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2890708B1 (en) * | 2012-08-28 | 2019-08-07 | The Governors of the University of Alberta | Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof |
| CA3045458A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| WO2019232283A1 (en) * | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| AU2021369193A1 (en) * | 2020-10-26 | 2023-06-01 | Purdue Research Foundation | Compounds,compositions and methods of use to treat spinal fusions |
-
2021
- 2021-08-26 US US18/033,665 patent/US20230399374A1/en active Pending
- 2021-08-26 WO PCT/US2021/047824 patent/WO2022093373A1/en not_active Ceased
- 2021-08-26 MX MX2023004796A patent/MX2023004796A/es unknown
- 2021-08-26 CA CA3194776A patent/CA3194776A1/en active Pending
- 2021-08-26 JP JP2023525002A patent/JP2024506435A/ja active Pending
- 2021-08-26 AU AU2021370296A patent/AU2021370296A1/en active Pending
- 2021-08-26 EP EP21887113.5A patent/EP4232074A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506435A5 (https=) | ||
| US10960054B2 (en) | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation | |
| CN1185252C (zh) | 生长激素释放抑制因子肽类 | |
| KR20170078668A (ko) | 이중 glp-1r 및 glp-2r 작용제 활성을 갖는 조성물 및 펩티드 | |
| JP2009544585A5 (https=) | ||
| JP2023547889A5 (https=) | ||
| JP2024506435A (ja) | 化合物、組成物、および骨折を処置するための使用方法 | |
| CN1279981C (zh) | 作为甲状旁腺激素片段的口服递送剂的5－cnac | |
| CN110139665B (zh) | 包含其中骨组织选择性肽与甲状旁腺激素(pth)或其片段结合的融合肽的药物组合物和生物材料 | |
| US20230390363A1 (en) | Compounds, Compositions and Methods of Use to Treat Spinal Fusions | |
| CN101837120A (zh) | 口服施用甲状旁腺激素和降钙素 | |
| WO2020065063A1 (en) | Formulations of glucagon-like-peptide-2 (glp-2) analogues | |
| KR100385697B1 (ko) | 올파드로네이트를포함하는골체량동화성조성물 | |
| JP2026509388A (ja) | 経口投与用のｇｌｐ作動薬の医薬組成物 | |
| JP4931306B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| CN116801900A (zh) | 用于治疗骨折的化合物、组合物和使用方法 | |
| JP5300943B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| AU2006311227B2 (en) | Use of clodronic acid for the treatment of navicular syndrome | |
| CN116710068A (zh) | 用于治疗脊柱融合的化合物、组合物和方法 | |
| CN1984864B (zh) | 芳基酮化合物及递送活性剂的组合物 | |
| JP2003002845A (ja) | 哺乳類の硬組織治療用組成物及びその治療方法 | |
| JP5454805B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| WO2021191903A1 (en) | Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof | |
| JPH0959177A (ja) | 消炎および／または鎮痛剤 | |
| JPWO2017006908A1 (ja) | 特発性大腿骨頭壊死症の発症予防及び／又は進行抑制剤 |